Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Backstrom Jay T. received 1,447 Agios Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Backstrom Jay T. (Director) received 1,447 Agios Pharmaceuticals, Inc. shares as an award, leaving 1,447 shares. Filed Jul 10, 2026 (Form 4).
- Awarded
- 1,447 shares
- Holding after
- 1,447 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common stock | Award | 1,447 | 1,447 | Direct |
Source
Related
- Agios Pharmaceuticals, Inc.
- Backstrom Jay T.
- Agios Pharmaceuticals, Inc. shareholders
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026
- Form 4 · Ballal Rahul D. · Jun 23, 2026